Epsilon aminocaproic acid prevents bleeding in severely thrombocytopenic patients with hematological malignancies. (يفتح نافذة جديدة)

Antun AG, Gleason S, Arellano M, Langston AA, McLemore ML, Gaddh M, el Rassi F, Bernal-Mizrachi L, Galipeau J, Heffner LT Jr, Winton EF, Khoury HJ.

Source‎: Cancer 2013;119(21):3784-7.

مفهرسة‎: PubMed 23921838

DOI‎: 10.1002/cncr.28253

https://www.ncbi.nlm.nih.gov/pubmed/23921838 (يفتح نافذة جديدة)

Low dose bolus aminocaproic acid: an alternative to platelet transfusion in thrombocytopenia? (يفتح نافذة جديدة)

Chakrabarti S, Varma S, Singh S, Kumari S

Source‎: Eur J Haematol 1998;60(5):313-4.

مفهرسة‎: PubMed 9654162

DOI‎: 10.1111/j.1600-0609.1998.tb01046.x

https://www.ncbi.nlm.nih.gov/pubmed/9654162 (يفتح نافذة جديدة)

The use of antifibrinolytics in pediatric patients with hypoproliferative thrombocytopenia. (يفتح نافذة جديدة)

Delaney M, Matthews DC, Gernsheimer TB

Source‎: Pediatr Blood Cancer 2017;64(12):e26641.

مفهرسة‎: PubMed 28544698

DOI‎: 10.1002/pbc.26641

https://www.ncbi.nlm.nih.gov/pubmed/28544698 (يفتح نافذة جديدة)

Preliminary experience with epsilon aminocaproic acid for treatment of intractable upper tract hematuria in children with hematological disorders. (يفتح نافذة جديدة)

Kaye JD, Smith EA, Kirsch AJ, Cerwinka WH, Elmore JM

Source‎: J Urol 2010;184(3):1152-7.

مفهرسة‎: PubMed 20650477

DOI‎: 10.1016/j.juro.2010.05.020

https://www.ncbi.nlm.nih.gov/pubmed/20650477 (يفتح نافذة جديدة)

A controlled trial of tranexamic acid therapy for the reduction of bleeding during treatment of acute myeloid leukemia. (يفتح نافذة جديدة)

Shpilberg O, Blumenthal R, Sofer O, Katz Y, Chetrit A, Ramot B, Eldor A, Ben-Bassat I.

Source‎: Leuk Lymphoma 1995;19(1-2):141-4.

مفهرسة‎: PubMed 8574160

DOI‎: 10.3109/10428199509059668

https://www.ncbi.nlm.nih.gov/pubmed/8574160 (يفتح نافذة جديدة)

Pediatric off-label use of recombinant factor VIIa. (يفتح نافذة جديدة)

Alten JA, Benner K, Green K, Toole B, Tofil NM, Winkler MK.

Source‎: Pediatrics 2009;123(3):1066-72.

مفهرسة‎: PubMed 19255041

DOI‎: 10.1542/peds.2008-1685

https://www.ncbi.nlm.nih.gov/pubmed/19255041 (يفتح نافذة جديدة)

Recombinant activated factor VII usage in life threatening hemorrhage: a pediatric experience. (يفتح نافذة جديدة)

Bhat S, Yadav SP, Anjan M, Dinand V, Sachdeva A.

Source‎: Indian J Pediatr 2011;78(8):961-8.

مفهرسة‎: PubMed 21328080

DOI‎: 10.1007/s12098-011-0364-6

https://www.ncbi.nlm.nih.gov/pubmed/21328080 (يفتح نافذة جديدة)

Control of bleeding caused by thrombocytopenia associated with hematologic malignancy: an audit of the clinical use of recombinant activated Factor VII. (يفتح نافذة جديدة)

Brenner B, Hoffman R, Balashov D, Shutluko E, Čulić SD, Nizamoutdinova E.

Source‎: Clin Appl Thromb Hemost 2005;11(4):401-10.

مفهرسة‎: PubMed 16244765

https://www.ncbi.nlm.nih.gov/pubmed/16244765 (يفتح نافذة جديدة)

Safety and efficacy of recombinant factor VIIa by pediatric age cohort: reassessment of compassionate use and trial data supporting US label. (يفتح نافذة جديدة)

Croteau SE, Nakar C, Neufeld EJ, Shapiro A, Cooper DL

Source‎: Pediatr Blood Cancer 2016;63(10):1822-8.

مفهرسة‎: PubMed 27232114

DOI‎: 10.1002/pbc.26082

https://www.ncbi.nlm.nih.gov/pubmed/27232114 (يفتح نافذة جديدة)

Use of recombinant factor VIIa prior to lumbar puncture in pediatric patients with acute leukemia. (يفتح نافذة جديدة)

Das P, Carcao M, Hitzler J

Source‎: Pediatr Blood Cancer 2006;47(2):206-9.

مفهرسة‎: PubMed 16007583

DOI‎: 10.1002/pbc.20467

https://www.ncbi.nlm.nih.gov/pubmed/16007583 (يفتح نافذة جديدة)

A comprehensive review of rFVIIa use in a tertiary care pediatric center. (يفتح نافذة جديدة)

Heller M, Lau W, Pazmino-Canizares J, Brandão LR, Carcao M

Source‎: Pediatr Blood Cancer 2008;50(5):1013-7.

مفهرسة‎: PubMed 17960639

DOI‎: 10.1002/pbc.21375

https://www.ncbi.nlm.nih.gov/pubmed/17960639 (يفتح نافذة جديدة)

Recombinant activated factor VII for severe gastrointestinal bleeding after chemotherapy in an infant with acute megakaryoblastic leukemia. (يفتح نافذة جديدة)

Kurekci AE, Atay AA, Okutan V, Yavuz ST, Ozcan O

Source‎: Blood Coagul Fibrinolysis 2005;16(2):145-7.

مفهرسة‎: PubMed 15741803

DOI‎: 10.1097/01.mbc.0000161569.66764.70

https://www.ncbi.nlm.nih.gov/pubmed/15741803 (يفتح نافذة جديدة)

Off-label use of recombinant factor VIIa in pediatric patients. (يفتح نافذة جديدة)

McQuilten ZK, Barnes C, Zatta A, Phillips LE; Haemostasis Registry Steering Committee

Source‎: Pediatrics 2012;129(6):e1533-40.

مفهرسة‎: PubMed 22641758

DOI‎: 10.1542/peds.2011-2561

https://www.ncbi.nlm.nih.gov/pubmed/22641758 (يفتح نافذة جديدة)

Dosing, efficacy, and safety of recombinant factor VIIa (rFVIIa) in pediatric versus adult patients: the experience of the Hemostasis and Thrombosis Research Society (HTRS) registry (2004-2008). (يفتح نافذة جديدة)

Neufeld EJ, Saxena K, Kessler CM, Cooper DL; HTRS Investigators

Source‎: Pediatr Blood Cancer 2013;60(7):1178-83.

مفهرسة‎: PubMed 23335449

DOI‎: 10.1002/pbc.24472

https://www.ncbi.nlm.nih.gov/pubmed/23335449 (يفتح نافذة جديدة)

Successful treatment of severe gastrointestinal bleeding after chemotherapy in acute myeloblastic leukemia with recombinant activated factor VII: report on one case and review of other uses in acute leukemias. (يفتح نافذة جديدة)

Pamuk GE, Taşçi M, Oztürk E, Demir M.

Source‎: Med Oncol 2010;27(1):16-9.

مفهرسة‎: PubMed 19137431

DOI‎: 10.1007/s12032-008-9163-y

https://www.ncbi.nlm.nih.gov/pubmed/19137431 (يفتح نافذة جديدة)

Successful treatment of acute lymphoblastic leukemia with l-asparaginase-induced intracranial hemorrhage to activated recombinant factor VIIa in a child. (يفتح نافذة جديدة)

Ucar C, Caliskan U

Source‎: Pediatr Hematol Oncol 2006;23(4):339-45.

مفهرسة‎: PubMed 16621776

DOI‎: 10.1080/08880010600631987

https://www.ncbi.nlm.nih.gov/pubmed/16621776 (يفتح نافذة جديدة)

Single-center experience: use of recombinant factor VIIa for acute life-threatening bleeding in children without congenital hemorrhagic disorder. (يفتح نافذة جديدة)

Yilmaz D, Karapinar B, Balkan C, Akisü M, Kavakli K.

Source‎: Pediatr Hematol Oncol 2008;25(4):301-11.

مفهرسة‎: PubMed 18484474

DOI‎: 10.1080/08880010802016904

https://www.ncbi.nlm.nih.gov/pubmed/18484474 (يفتح نافذة جديدة)

The use of DDAVP in children with bleeding disorders. (يفتح نافذة جديدة)

Ben-Ami T, Revel-Vilk S

Source‎: Pediatr Blood Cancer 2013;60 Suppl 1:S41-3.

مفهرسة‎: PubMed 23109357

DOI‎: 10.1002/pbc.24335

https://www.ncbi.nlm.nih.gov/pubmed/23109357 (يفتح نافذة جديدة)

Treatment of refractory thrombocytopenic bleeding with 1-desamino-8-D-arginine vasopressin (desmopressin). (يفتح نافذة جديدة)

Kobrinsky NL, Tulloch H

Source‎: J Pediatr 1988;112(6):993-6.

مفهرسة‎: PubMed 3373409

DOI‎: 10.1016/s0022-3476(88)80234-8

https://www.ncbi.nlm.nih.gov/pubmed/3373409 (يفتح نافذة جديدة)

The use of Tachosil as hemostatic sealant in nephron sparing surgery for Wilms tumor: preliminary observations. (يفتح نافذة جديدة)

Mele E, Ceccanti S, Schiavetti A, Bosco S, Masselli G, Cozzi DA

Source‎: J Pediatr Surg 2013;48(3):689-94.

مفهرسة‎: PubMed 23480936

DOI‎: 10.1016/j.jpedsurg.2013.01.019

https://www.ncbi.nlm.nih.gov/pubmed/23480936 (يفتح نافذة جديدة)